Showing 1 - 7 results of 7 for search 'Shi Zuo', query time: 0.02s Refine Results
  1. 1
    A 0.8 V, 5.3–5.9 GHz Sub-Sampling PLL with 196.5 fs<sub><i>rms</i></sub> Integrated Jitter and −251.6 dB FoM

    A 0.8 V, 5.3–5.9 GHz Sub-Sampling PLL with 196.5 fs<sub><i>rms</i></sub> Integrated Jitter and −251.6 dB FoM by Shi Zuo, Jianzhong Zhao, Yumei Zhou

    Published 2021-11-01
    Get full text
    Article
  2. 2
    Efficacy and safety of atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma in the real world: a single-arm meta-analysis

    Efficacy and safety of atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma in the real world: a single-arm meta-analysis by Xiaoqiang Gao, Rui Zhao, Huaxing Ma, Shi Zuo

    Published 2023-07-01
    Get full text
    Article
  3. 3
    Retirement planning with CPF and CPFIS investing behaviour

    Retirement planning with CPF and CPFIS investing behaviour by Bong, Siaw Phun, Kek, Xin Yan, Shi, Zuo

    Published 2008
    Get full text
    Final Year Project (FYP)
  4. 4
    Autophagy: Regulator of cell death

    Autophagy: Regulator of cell death by ShiZuo Liu, ShuaiJie Yao, Huan Yang, ShuaiJie Liu, YanJiao Wang

    Published 2023-10-01
    Get full text
    Article
  5. 5
    Letter to the editor: “Utilization of CT and MRI scanning in Taiwan, 2000–2017”

    Letter to the editor: “Utilization of CT and MRI scanning in Taiwan, 2000–2017” by Hao-Ming Li, Shi-Zuo Liu, Lee-Ren Yeh, Nan-Han Lu, Liang-Yi Wang

    Published 2023-05-01
    Get full text
    Article
  6. 6
    A Differentiation-Related Gene Prognostic Index Contributes to Prognosis and Immunotherapy Evaluation in Patients with Hepatocellular Carcinoma

    A Differentiation-Related Gene Prognostic Index Contributes to Prognosis and Immunotherapy Evaluation in Patients with Hepatocellular Carcinoma by Jingjing Xiao, Tao Liu, Zhenhua Liu, Chuan Xiao, Jun Du, Shi Zuo, Haiyang Li, Huajian Gu

    Published 2022-07-01
    Get full text
    Article
  7. 7
    NAP1L1 regulates BIRC2 ubiquitination modification via E3 ubiquitin ligase UBR4 and hence determines hepatocellular carcinoma progression

    NAP1L1 regulates BIRC2 ubiquitination modification via E3 ubiquitin ligase UBR4 and hence determines hepatocellular carcinoma progression by Shi-Long Zhang, Shen-Jie Zhang, Lian Li, Ye-Wei Zhang, Zhi Wang, Long Wang, Jie-Yu Lu, Teng-Xiang Chen, Shi Zuo

    Published 2024-03-01
    Get full text
    Article

Search Tools: